دانلود کتاب Ciba Foundation Symposium 39 - Monoamine Oxidase and its Inhibition

Content: Chapter 1 Introduction (pages 1–4): S. S. KetyChapter 2 The Nature and Locations of the Multiple forms of Monoamine Oxidase (pages 5–31): K. F. Tipton, M. D. Houslay and T. J. MantleChapter 3 The Action of Acetylenic Inhibitors on Mitochondrial Monoamine Oxidase: Structure of the Flavin Site in the Inhibited Enzyme (pages 33–47): A. L. Maycock, Robert H. Abeles, J. I. Salach and Thomas P. SingerChapter 4 Cysteinyl Flavin in Monoamine Oxidase from the Central Nervous System (pages 49–59): J. I. Salach, T. P. Singer, K. T. Yasunobu, N. Minamiurat and M. B. H. YoudimChapter 5 Monoamine Oxidase Inhibitors and the Transformation of Monoamine Oxidases (pages 61–81): V. Z. GorkinChapter 6 Nutritional Requirements for Amine Metabolism in vivo (pages 83–103): Theodore L. Sourkes and Krystyna MissalaChapter 7 Physiological Aspects of the Oxidative Deamination of Monoamines (pages 105–133): M. B. H. Youdim and Margarethe HolzbauertChapter 8 Analysis of the Pharmacological Effects of Selective Monoamine Oxidase Inhibitors (pages 135–161): J. KnollChapter 9 The Use of Selective Monoamine Oxidase Inhibitor Drugs for Evaluating Pharmacological and Physiological Mechanisms (pages 163–179): Norton H. Neff and Jose A. FuentesChapter 10 The Part Played by Mono Amine Oxidase in the Inactivation of Catecholamines in Intact Tissues (pages 181–201): U. Trendelenburg, K. H. Graefe and M. HenselingChapter 11 Can the Intra? and Extra?Homoneuronal Metabolism of Cate?Cholamines be Distinguished in the Mammalian Central Nervous System? (pages 203–229): D. F. SharmanChapter 12 Use of a Behavioural Model to Study the Action of Monoamine Oxidase Inhibition in vivo (pages 231–245): A. Richard Green and Moussa B. H. YoudimChapter 13 Relations Between the Degree of Monoamine Oxidase Inhibition and Some Psychopharmacological Responses to Monoamine Oxidase Inhibitors in Rats (pages 247–270): L. Mai?tre, A. Delini?Stula and P. C. WaldmeierChapter 14 Introduction to Clinical Aspects of Monoamine Oxidase Inhibitors in the Treatment of Depression (pages 271–296): C. M. B. PareChapter 15 The Relationship Between Classification and Response to Drugs in Affective Disorders—Problems Posed by Drug Response in Affective Disorders (pages 297–325): M. Roth, C. Gurney, C. Q. Mountjoy, T. A. Kerr and K. SchapiraChapter 16 Variations in Monoamine Oxidase Activity in Some Human Disease States (pages 327–340): M. SandlerChapter 17 Clinical, Genetic, Hormonal and Drug Influences on the Activity of Human Platelet Monoamine Oxidase (pages 341–351): Dennis L. MurphyChapter 18 An Investigation of Platelet Monoamine Oxidase Activity in Schizophrenia and Schizoaffective Psychosis (pages 353–388): I. Brockington, T. J. Crow, Eve C. Johnstone and F. OwenChapter 19 Conclusion (pages 389–391): S. S. Kety